Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
42 hedge funds and large institutions have $74.3M invested in Apollo Endosurgery, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 2 closing their positions.
700% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 2
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
68% more capital invested
Capital invested by funds: $44.2M → $74.3M (+$30.1M)
51% more call options, than puts
Call options by funds: $216K | Put options by funds: $143K
50% more funds holding
Funds holding: 28 → 42 (+14)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.86M |
| 2 |
Renaissance Technologies
New York
|
+$896K |
| 3 |
SCM
SG Capital Management
Chicago,
Illinois
|
+$739K |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$650K |
| 5 |
GS
Gagnon Securities
New York
|
+$563K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.34M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$441K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$46K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.2K |
| 5 |
RWA
Ropes Wealth Advisors
Boston,
Massachusetts
|
-$3K |
APEN Hedge Fund Activity: Q1 2021 in Review
42 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2021, worth a combined $74.3M — up 68% from $44.2M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new APEN positions and 2 closed out — a net gain of 14 holders — while 11 added to existing stakes and 5 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $1.86M. The largest seller was Stonepine Capital Management, cutting an estimated $4.34M.
- 42 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2021, up from 28 in Q4 2020.
- Funds reported $74.3M of Apollo Endosurgery, Inc. stock for Q1 2021, up 68% quarter-over-quarter.
- 16 funds opened new Apollo Endosurgery, Inc. positions in Q1 2021 and 2 closed out, a net change of +14 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q1 2021 was Marshall Wace, an estimated $1.86M added.
- The largest Apollo Endosurgery, Inc. seller in Q1 2021 was Stonepine Capital Management, an estimated $4.34M sold.
Based on aggregated 13F filings for Q1 2021.